Article

Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications

2007-12-01

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 058034e2-7e38-5bb5-b050-604d8241f1a3
DOI: 10.1089/blr.2007.9905

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease IndicationsDOI 10.1089/blr.2007.9905Read

Plasmid BiopharmaceuticalsSemantic proximity Read

Technical and regulatory hurdles for DNA vaccinesSemantic proximity Read

Using Plasmids as DNA Vaccines for Infectious DiseasesSemantic proximity Read

From Plasmids to Protection: A Review of DNA Vaccines Against Infectious DiseasesSemantic proximity Read

Ensuring safety of DNA vaccinesSemantic proximity Read

DNA-Based Nonviral Gene Therapy─Challenging but PromisingSemantic proximity Read

DNA vaccines for viral diseasesSemantic proximity Read

Vector Design for Improved DNA Vaccine Efficacy, Safety and ProductionSemantic proximity Read

The future of human DNA vaccinesSemantic proximity Read

A Brief Review on Dna Vaccines in the Era of COVID-19Semantic proximity Read

DNA Vaccines Approach: From Concepts to ApplicationsSemantic proximity Read

Improving DNA Vaccine Performance Through Vector DesignSemantic proximity Read